Clinical Trials Logo

Vitreomacular Adhesion clinical trials

View clinical trials related to Vitreomacular Adhesion.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02001701 Withdrawn - Clinical trials for Vitreomacular Adhesion

Intravitreal Gas for Vitreomacular Adhesion

RELEASE
Start date: November 2013
Phase: N/A
Study type: Interventional

Vitreomacular adhesion causes symptoms of blurry vision, distortion, and double vision. It is due to an abnormal separation of the vitreous gel from the surface of the retina and macula. The current, gold-standard treatment for this condition involves surgery performed in the operating room that involves risk such as bleeding, infection, cataract, and retinal detachment. It has been previously shown that a less invasive intravitreal injection of a gas bubble performed in the office may also treat vitreomacular adhesion with less risk than surgery. The purpose of this study is to determine the effect of an office-based injection of an intravitreal gas bubble as a treatment for symptomatic vitreomacular adhesion.